virus in red image
A 6-mRNA host response using patients with non-COVID-19 infections accurately predicts severity of COVID-19
Gallery

A 6-mRNA host response using patients with non-COVID-19 infections accurately predicts severity of COVID-19

, ,

A 6-mRNA host response using patients with non-COVID-19 infections accurately predicts severity of COVID-19

, ,
2022-03-02T14:37:42-08:00

Buturovic, L. et. al. Nature, Jan. 2022.

Virus back ground in blue
Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in Coronavirus disease 2019
Gallery

Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in Coronavirus disease 2019

,

Validation of inflammopathic, adaptive, and coagulopathic sepsis endotypes in Coronavirus disease 2019

,
2021-07-09T11:00:15-07:00

Sweeney, T. et al. Critical Care Medicine. Feb 2021.

Virus zoomed image
Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections
Gallery

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

,

Transcriptomic similarities and differences in host response between SARS-CoV-2 and other viral infections

,
2021-07-09T11:01:55-07:00

Thair, S. et al. Science Direct. Dec 2020.

Inflammatix is reimagining diagnostics by developing rapid tests that read the immune system to resolve major clinical and public health challenges. Our initial focus is on acute bacterial and viral infections, and sepsis.

We’re seeking teammates with expertise, curiosity and passion for solving clinical challenges with a focus on patient outcomes. If that sounds like you, check out our Careers Page.

© Copyright , Inflammatix, Inc.     All Rights Reserved   |   Terms & Conditions   |   Privacy & Cookies Statement
Products in development, are not for sale, and do not have marketing approval or clearance from regulatory authorities in any jurisdiction.
LinkedInTwitter
Go to Top